Medication info
Glipame M Tablet 2/500 mg

Glipame M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201107003 · Notified 2011.09.23 · Insurance code 642904270

Summary

Main use
Improves glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in managing their blood sugar levels through diet and exercise by improving blood glucose control.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis and hypoglycemia; therefore, it should be discontinued and a physician consulted, especially if kidney function declines sharply. If there is dehydration, severe diarrhea, vomiting, or fever, the use of this medication should be temporarily stopped and medical personnel notified. Patients with poor kidney function or the elderly must test kidney function before taking this medication and regularly monitor kidney function. Patients at risk for cardiovascular disease should be cautious when taking this medication and thoroughly discuss the benefits and risks with healthcare personnel. This medication is contraindicated for patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant women, and nursing mothers. Before and after tests using radioactive iodine contrast agents, this medication should be temporarily stopped and not retaken until kidney function stabilizes. Patients at high risk for hypoglycemia, malnourished patients, and those consuming excessive alcohol should take additional precautions when using this medication. Gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.) may occur at the beginning of treatment, and patients should consult a doctor if symptoms are severe. During the use of this medication, regular monitoring of blood sugar and glycated hemoglobin is recommended, as well as monitoring of vitamin B12 levels. When used in conjunction with other medications, drug interactions may occur, so all medications being taken should be reported to healthcare personnel. If symptoms of hypoglycemia occur, immediate intake of sugar is necessary, and if symptoms are severe, immediate medical attention is required. Women who are pregnant or planning to become pregnant should consider switching to insulin therapy instead of this medication for safety. The safety and effectiveness of this medication in children and adolescents have not been sufficiently confirmed, thus special caution is necessary when used. Elderly patients commonly have declining kidney function, making dosage adjustment and kidney function tests even more important. Care should be taken when driving or operating machinery, as hypoglycemia or impaired agility may occur.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, anorexia, dyspepsia, constipation, abdominal pain, discomfort, metallic taste, visual impairment, taste disorder, erythema, pruritus, urticaria, rash, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, vitamin B12 deficiency, peripheral neuropathy, increased liver enzymes, liver dysfunction, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, abdominal pain, abdominal bloating, vomiting, dyspepsia, palpitations, dizziness, diarrhea, nausea, leg swelling, cardiac arrest, rectal carcinoma, hypoglycemia, dizziness, liver dysfunction, arthralgia, facial swelling, impotence, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is recommended to keep it at a temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication and prevents degradation.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.